Somatic mosaicism in FSHD often goes undetected

被引:62
作者
Lemmers, RJLF
van der Wielen, MJR
Bakker, E
Padberg, GW
Frants, RR
van der Maarel, SM
机构
[1] Leiden Univ, Ctr Med, Ctr Human & Clin Genet, NL-2333 AL Leiden, Netherlands
[2] Univ Nijmegen, Ctr Med, Dept Neurol, Nijmegen, Netherlands
关键词
D O I
10.1002/ana.20106
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Autosomal dominant facioscapulohumeral muscular dystrophy (FSHD1A) is associated with contractions of the polymorphic D4Z4 repeat array on chromosome 4qter. The disease has a high frequency of new mutations of mitotic origin. Pulsed-field gel electrophoresis-based studies show that mitotic mutations leading to somatic mosaicism occur equally frequently in patients and parents. Nevertheless, somatic mosaicism in FSHD is mainly reported in asymptomatic parents by applying standard Southern analysis after linear gel electrophoresis. Explaining this apparent discrepancy, we here demonstrate that somatic mosaicism in FSHD patients goes largely undetected using the standard diagnostic technique, indicating that linear electrophoresis is unsuitable to identify mosaic patients. As a consequence, the phenotype of mosaic patient's offspring will be underestimated, whereas the recurrence risk in the symptomatic mosaic individuals win be overestimated. Moreover, somatic mosaicism may partly explain the observation of anticipation in de novo kindreds. Therefore, clinicians should always consider pulsed-field gel electrophoresis analysis in de novo FSHD families, in particular when the patient's phenotype is much milder than expected based on D4Z4 length proper.
引用
收藏
页码:845 / 850
页数:6
相关论文
共 27 条
[1]   Diagnostic, predictive, and prenatal testing for facioscapulohumeral muscular dystrophy: Diagnostic approach for sporadic and familial cases [J].
Bakker, E ;
VanderWielen, MJR ;
Voorhoeve, E ;
Ippel, PF ;
Padberg, GW ;
Frants, RR ;
Wijmenga, C .
JOURNAL OF MEDICAL GENETICS, 1996, 33 (01) :29-35
[2]  
BAKKER E, 1995, MUSCLE NERVE S, V2, P39
[3]  
Brooke MH, 1977, CLIN VIEW NEUROMUSCU
[4]   HEARING-LOSS IN FACIOSCAPULOHUMERAL MUSCULAR-DYSTROPHY [J].
BROUWER, OF ;
PADBERG, GW ;
RUYS, CJM ;
BRAND, R ;
DELAAT, JAPM ;
GROTE, JJ .
NEUROLOGY, 1991, 41 (12) :1878-1881
[5]  
DEIDDA G, 1995, EUR J HUM GENET, V3, P155
[6]  
DENDUNNEN JT, 1993, APPL BIOCHEM BIOTECH, V38, P161
[7]   Molecular analysis of 4q35 rearrangements in facioscapulohumeral muscular dystrophy (FSHD):: application to family studies for a correct genetic advice and a reliable prenatal diagnosis of the disease [J].
Galluzzi, G ;
Deidda, G ;
Cacurri, S ;
Colantoni, L ;
Piazzo, N ;
Vigneti, E ;
Ricci, E ;
Servidei, S ;
Merico, B ;
Pachì, A ;
Brambati, B ;
Mangiola, F ;
Tonali, P ;
Felicetti, L .
NEUROMUSCULAR DISORDERS, 1999, 9 (03) :190-198
[8]   Germline mosaicism in 4q35 facioscapulohumeral muscular dystrophy (FSHD1A) occurring predominantly in oogenesis [J].
Kohler, J ;
Rupilius, B ;
Otto, M ;
Bathke, K ;
Koch, MC .
HUMAN GENETICS, 1996, 98 (04) :485-490
[9]   Complete allele information in the diagnosis of facioscapulohumeral muscular dystrophy by triple DNA analysis [J].
Lernmers, RJLF ;
de Kievit, P ;
van Geel, M ;
van der Wielen, MJR ;
Bakker, E ;
Padberg, GW ;
Frants, RR ;
van der Maarel, SM .
ANNALS OF NEUROLOGY, 2001, 50 (06) :816-819
[10]   Expanded repeat sequences and disease [J].
Lindblad, K ;
Schalling, M .
SEMINARS IN NEUROLOGY, 1999, 19 (03) :289-299